The predictive value of ALT, HBeAg and HBV DNA levels at baseline and the degree of HBV suppression at week 12 adefovir dipivoxil treatment to the efficacy of it at week 52 in patients with HBeAg-positive chronic hepatitis B
Dong-ying XIE; Bing-liang LIN; Qi-huan XU; You-ming CHEN; Wei-lun LU; Jian-guo LI; Zhi-liang GAO.
Artículo
en Zh
| WPRIM | ID: wpr-332239